Sikiric's lab in Croatia) No independent replication No competing research Raises red flags about bias Human data: ONE small retrospective study (not a randomized trial) No large-scale clinical trials No safety studies Unknown dosing Unknown side effects Recent systematic review (2024): Published in orthopaedic literature, concluded: "BPC-157 has potential based on preclinical data, but there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without publication." Reported Side Effects (From Online Users): Anonymous reports include: Injection site pain and swelling Joint pain Anxiety and panic attacks Heart palpitations Insomnia or drowsiness Fatigue and weakness Loss of appetite Depression and anhedonia (inability to feel pleasure) Note: These are anecdotal, not from clinical trials
We ensure responsible sermorelin prescribing for every patient
But, blood levels tank with age
Thase, M.E
In 2022, Pfizer officially published a paper in the Journal of Medicinal Chemistry, disclosing the development process of PF-06882961
Dietary Quality: Low sugar, low calorie, gluten-free, non-GMO, and free from harsh heavy chemical preservatives or synthetic binders